Cellectar Biosciences, Inc. Debt Instrument, Interest Rate, Effective Percentage
Cellectar Biosciences, Inc. (CLRB) had Debt Instrument, Interest Rate, Effective Percentage of 12.00% as of 2014-02-05, per its 10-Q filed 2014-08-04.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentInterestRateEffectivePercentage · last filed 2014-08-04
- 2014-02-05: Debt Instrument, Interest Rate, Effective Percentage 12.00%.
| Period end | Debt Instrument, Interest Rate, Effective Percentage |
|---|---|
| 2014-02-05 | 12.00% 10-Q · filed 2014-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |